We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


GenMark Submits Respiratory Viral Panel Test for FDA 510(k) Clearance

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "GenMark Submits Respiratory Viral Panel Test for FDA 510(k) Clearance"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The eSensor Respiratory Viral Panel is designed to be a fast, easy-to-use molecular diagnostic test to provide accurate results while requiring less technologist time.

"The submission to the FDA of our eSensor Respiratory Viral Panel is an important step in GenMark's continued commitment to providing our customers with high quality in-vitro diagnostic molecular tests for use with our award winning eSensor XT-8 system," commented Hany Massarany, President and CEO of GenMark Diagnostics.